A Bioequivalence Study Between Fluticasone Propionate 100 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 Inhalation Powder/GSK in Healthy Volunteers
Clinical trial NCT03975166 · COMPLETED
Trial details
- NCT number
- NCT03975166
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-21
- Primary completion
- 2019-06-25
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.